Janice Man, MD, is currently a clinical instructor for the Department of Anesthesia, Perioperative and Pain Medicine at Stanford University and is board-certified in anesthesiology and pediatric anesthesiology. She completed her medical school education at the Yale University School of Medicine, residency training at UCSF, pediatric anesthesia fellowship training at CHOP, and her pediatric regional anesthesia fellowship at Stanford. She received the Outstanding Research Award in Acute Pain at the Society of Pediatric Pain Medicine Annual Conference in 2016. Her interests include utilization of regional anesthesia and comprehensive multimodal analgesic protocols in the reduction of opioid consumption for acute pain in pediatric patients.

Clinical Focus

  • Pediatric Anesthesia
  • Pediatric Regional Anesthesia
  • Pediatric Acute Pain
  • Fetal Anesthesia
  • Simulation in Medical Education

Academic Appointments

Honors & Awards

  • Outstanding Research Award in Acute Pain, Society of Pediatric Pain Medicine Annual Meeting (2016)
  • Patient-Oriented Research Poster Award in Anesthesiology & Critical Care Medicine, CHOP Research Poster Day (2016)

Boards, Advisory Committees, Professional Organizations

  • Member, Society of Pediatric Anesthesia - Simulation SIG (2016 - Present)
  • Member, Society of Pediatric Anesthesia - SPAIN Committee (2016 - Present)
  • Member, LPCH Pediatric Anesthesia Safety Committe (2017 - Present)
  • Member, LPCH Pediatric Anesthesia Professional Practice Evaluation Committee (2017 - Present)
  • Member, Wake Up Safe (2018 - Present)

Professional Education

  • Board Certification: Pediatric Anesthesia, American Board of Anesthesiology (2016)
  • Board Certification: Anesthesia, American Board of Anesthesiology (2016)
  • Fellowship:The Children's Hospital of Philadelphia (2016) PA
  • Residency:University of California San Francisco (2015) CA
  • Internship:California Pacific Medical Center (2012) CA
  • Medical Education:Yale School Of Medicine Office of Student Affairs (2011) CT
  • Board Certification, Pediatric Anesthesiology (2016)
  • Board Certification, Anesthesiology (2016)
  • Fellowship, The Children's Hospital of Philadelphia, Pediatric Anesthesiology (2016)
  • Residency, University of California, San Francisco, Anesthesiology (2015)
  • Internship, California Pacific Medical Center, Internal Medicine (2012)
  • MD, Yale University School of Medicine (2011)


All Publications

  • Technique Utilizing a Modified Oral Ring-Adair-Elwyn Tube to Provide Continuous Oxygen and Sevoflurane Delivery During Nasotracheal Intubation in an Infant With a Difficult Airway: A Case Report. A & A case reports Man, J. Y., Fiadjoe, J. E., Hsu, G. 2017


    Managing the airway of an infant with Pierre Robin sequence (PRS) is particularly challenging for anesthesiologists. Patients with PRS have the triad of micrognathia, glossoptosis, and airway obstruction that potentially and frequently leads to difficulty with both ventilation and intubation. Thus continuous oxygenation and spontaneous ventilation during intubation are essential. We describe a new method to deliver continuous oxygen and volatile anesthetic during nasotracheal intubation in an infant with PRS.

    View details for DOI 10.1213/XAA.0000000000000677

    View details for PubMedID 29210721

  • A retrospective comparison of thoracic epidural infusion and multimodal analgesia protocol for pain management following the minimally invasive repair of pectus excavatum. Paediatric anaesthesia Man, J. Y., Gurnaney, H. G., Dubow, S. R., DiMaggio, T. J., Kroeplin, G. R., Adzick, N. S., Muhly, W. T. 2017; 27 (12): 1227–34


    Pain management following minimally invasive repair of pectus excavatum is variable. We recently adopted a comprehensive multimodal analgesic protocol that standardizes perioperative analgesic management. We hypothesized that patients managed with this protocol would use more opioids postoperatively, have similar pain control, and shorter length of stay compared to patients managed with thoracic epidural infusion.We retrospectively compared opioid consumption, pain scores, and length of stay between a cohort of patients managed with our multimodal analgesic protocol and a cohort managed with a thoracic epidural infusion.This retrospective cohort comparison includes patients, 8 to 21 years of age, managed with either thoracic epidural infusion (n = 21) or multimodal analgesic protocol (n = 29) following minimally invasive repair of pectus excavatum from January 1, 2011 through September 15, 2015. The primary outcome, total daily opioid consumption in morphine equivalents, is presented as an average by postoperative day. Secondary outcomes included median daily pain score and length of stay.Patients were similar in age, weight, sex, and physical status. Patients managed with thoracic epidural infusion received less opioid (morphine equivalents-mg/kg) intraoperatively compared to multimodal analgesic protocol (difference of mean [95% confidence interval] 0.22 [0.16-0.28] P ≤ .01) but required more total opioid through postoperative day 3 (difference of mean [95% confidence interval] 1.2 [0.26-2.14] P = .01). We did not observe a difference in pain scores. Median length of stay was 1 day less in patients managed with multimodal analgesic protocol (difference of median [95% confidence interval] 1 [0.3-1.7] P = .003).Implementation of a standardized comprehensive multimodal analgesic protocol following minimally invasive repair of pectus excavatum resulted in equivalent analgesia with a modest reduction in length of stay when compared to thoracic epidural. We did not observe an opioid sparing effect in our thoracic epidural which may reflect technique variability.

    View details for DOI 10.1111/pan.13264

    View details for PubMedID 29063665

  • The role of CD8(+) T-cell replicative senescence in human aging IMMUNOLOGICAL REVIEWS Effros, R. B., Dagarag, M., Spaulding, C., Man, J. 2005; 205: 147-157


    The strict limit in proliferative potential of normal human somatic cells - a process known as replicative senescence - is highly relevant to the immune system, because clonal expansion is fundamental to adaptive immunity. CD8(+) T cells that undergo extensive rounds of antigen-driven proliferation in cell culture invariably reach the end stage of replicative senescence, characterized by irreversible cell-cycle arrest and a critically short telomere length. Cultures of senescent CD8(+) T cells also show resistance to apoptosis, permanent loss of CD28 expression, altered cytokine profiles, reduced ability to respond to stress, and various functional changes. Cells with similar characteristics accumulate during normal aging as well as in younger persons infected with human immunodeficiency virus, suggesting that the process of replicative senescence is not an artifact of cell culture but is also occurring in vivo. Interestingly, in elderly persons, the presence of high proportions of CD8(+) T cells with characteristics of replicative senescence is correlated with reduced antibody responses to vaccines as well as with osteoporotic fractures. CD8(+)CD28(-) T cells also accumulate in patients with certain types of cancer. The emerging picture is that senescent CD8(+) T cells may modulate both immune and non-immune functions, contributing not only to reduced anti-viral immunity but also to diverse age-related pathologies.

    View details for Web of Science ID 000228976300012

    View details for PubMedID 15882351